SCHEMBL124960

SCHEMBL124960

C1=CNCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22243016 0.97 ALDH1A1 (0.30)
SCHEMBL1089803 0.97 ALDH1A1 (0.30)
SCHEMBL1088944 0.97
SCHEMBL1089804 0.97 ALDH1A1 (0.30)
SCHEMBL339936 0.97
SCHEMBL25134064 0.97 ALDH1A1 (0.30)
SCHEMBL339935 0.97
SCHEMBL8065057 0.97
SCHEMBL13562 0.90
SCHEMBL7212633 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2373 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119823111-A Condensed imide derivative 正大天晴药业集团股份有限公司 2025-04-15 CN claimed
WO-2025040147-A1 CYCLOBUTYL-CONTAINING COMPOUNDS 正大天晴药业集团股份有限公司 2025-02-27 WO claimed
CN-118201935-A Condensed imide derivative 正大天晴药业集团股份有限公司 2024-06-14 CN claimed
US-20230225190-A1 LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE ORGANOMETALLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-13 US claimed
WO-2023088406-A1 FUSED IMIDE DERIVATIVE 正大天晴药业集团股份有限公司 2023-05-25 WO claimed
CN-111372931-B Heterocyclic compounds as protein kinase inhibitors 怡诺安有限公司 2023-03-24 CN claimed
CN-110759913-B Indolylhydrazone derivatives, preparation method thereof and application thereof in plant virus prevention and control, sterilization and disinsection 南开大学 2022-01-28 CN claimed
CN-113861128-A Polymerizable compound and optically anisotropic body 江苏创拓新材料有限公司 2021-12-31 CN claimed
US-10703725-B2 Process for producing novel 4-benzoazonine derivatives NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 2020-07-07 US claimed
US-10556891-B2 Compositions and methods for inhibition of the JAK pathway RIGEL PHARMACEUTICALS, INC. (US) 2020-02-11 US claimed
EP-0502439-B1 Purification of 6-Aminocapronitrile DU PONT (US) 1994-09-14 EP claimed
US-5296495-A Antiallergens, antiinflammatory FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-03-22 US claimed
WO-1993016984-A1 PURIFICATION OF 6-AMINOCAPRONITRILE E.I. DU PONT DE NEMOURS AND COMPANY (US) 1993-09-02 WO claimed
WO-1993014064-A1 REMOVAL OF TETRAHYDROAZEPINE (THA) FROM 6-AMINOCAPRONITRILE BY REACTION WITH REACTIVE METHYLENE COMPOUNDS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1993-07-22 WO claimed
US-5192399-A Adding caustic compound and separating by low pressure distillation E. I. DU PONT DE NEMOURS AND COMPANY (US) 1993-03-09 US claimed
US-5162567-A Purification of 6-aminocapronitrile E. I. DU PONT DE NEMOURS AND COMPANY (US) 1992-11-10 US claimed
US-5153351-A Removal of tetrahydroazepine (tha) from 6-aminocapronitrile by reaction with reactive methylene compounds E. I. DU PONT DE NEMOURS AND COMPANY (US) 1992-10-06 US claimed
EP-0502439-A1 Purification of 6-Aminocapronitrile E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-09-09 EP claimed
EP-0497333-A2 Purification of aminonitriles or diamines E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-08-05 EP claimed
US-5133838-A PURIFICATION OF 6-AMINOCAPRONITRILE E. I. DU PONT DE NEMOURS AND COMPANY (US) 1992-07-28 US claimed